Correction: Treatment Landscape and Prognosis After Treatment with Trastuzumab Emtansine.


Journal

Geburtshilfe und Frauenheilkunde
ISSN: 0016-5751
Titre abrégé: Geburtshilfe Frauenheilkd
Pays: Germany
ID NLM: 0370732

Informations de publication

Date de publication:
Nov 2020
Historique:
entrez: 2 12 2020
pubmed: 3 12 2020
medline: 3 12 2020
Statut: ppublish

Résumé

[This corrects the article DOI: 10.1055/a-1286-2917.].

Identifiants

pubmed: 33262544
doi: 10.1055/a-1306-7231
pii: 12862917err
pmc: PMC7688407
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

e289

Commentaires et corrections

Type : ErratumFor

Informations de copyright

The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Auteurs

Elena Laakmann (E)

Department of Gynecology, Hamburg-Eppendorf University Medical Center, Hamburg, Germany.

Julius Emons (J)

Erlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.

Florin-Andrei Taran (FA)

Department of Gynecology, Zurich University Hospital, Zurich, Switzerland.

Wolfgang Janni (W)

Department of Gynecology and Obstetrics, Ulm University Hospital, Ulm, Germany.

Sabrina Uhrig (S)

Erlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.

Friedrich Overkamp (F)

Oncologianova GmbH, Recklinghausen, Germany.

Hans-Christian Kolberg (HC)

Department of Marienhospital Bottrop, Bottrop, Germany.

Peyman Hadji (P)

Frankfurt Center of Bone Health Frankfurt, Frankfurt, Germany.

Hans Tesch (H)

Oncology Practice at Bethanien Hospital Frankfurt, Frankfurt, Germany.

Lothar Häberle (L)

Erlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Biostatistics Unit, University Hospital Erlangen, Department of Gynecology and Obstetrics, Erlangen, Germany.

Johannes Ettl (J)

Department of Obstetrics and Gynecology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.

Diana Lüftner (D)

Charité University Hospital, Berlin, Department of Hematology, Oncology and Tumour Immunology, Berlin, Germany.

Markus Wallwiener (M)

Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.

Carla Schulmeyer (C)

Erlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.

Volkmar Müller (V)

Department of Gynecology, Hamburg-Eppendorf University Medical Center, Hamburg, Germany.

Matthias W Beckmann (MW)

Erlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.

Erik Belleville (E)

ClinSol GmbH & Co. KG, Würzburg, Germany.

Pauline Wimberger (P)

National Center for Tumor Diseases (NCT), Dresden, Germany.
German Cancer Research Center (DKFZ), Heidelberg, Germany.
Carl Gustav Carus Faculty of Medicine and University Hospital, TU Dresden, Dresden, Germany.
Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.

Carsten Hielscher (C)

g.SUND Center for Gynecologic Oncology Stralsund, Stralsund, Germany.

Christian Kurbacher (C)

Department of Gynecology I (Gynecologic Oncology), Gynecologic Center Bonn-Friedensplatz, Bonn, Germany.

Rachel Wuerstlein (R)

Department of Gynecology and Obstetrics, Breast Center and CCC Munich, University Hospital Munich LMU, Munich, Germany.

Christoph Thomssen (C)

Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.

Michael Untch (M)

Department of Gynecology and Obstetrics, Helios Clinics Berlin Buch, Berlin, Germany.

Bernhard Volz (B)

Ansbach University of Applied Sciences, Ansbach, Germany.

Peter A Fasching (PA)

Erlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.

Tanja N Fehm (TN)

Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Düsseldorf, Germany.

Diethelm Wallwiener (D)

Department of Obstetrics and Gynecology, University of Tübingen, Tübingen, Germany.

Sara Y Brucker (SY)

Department of Obstetrics and Gynecology, University of Tübingen, Tübingen, Germany.

Andreas Schneeweiss (A)

National Center for Tumor Diseases, Heidelberg University Hospital, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Michael P Lux (MP)

Department of Gynecology and Obstetrics, Frauenklinik St. Louise, Paderborn, St. Josefs-Krankenhaus, Salzkotten, Germany; Kooperatives Brustzentrum Paderborn, Paderborn, Germany.

Andreas D Hartkopf (AD)

Department of Obstetrics and Gynecology, University of Tübingen, Tübingen, Germany.

Classifications MeSH